DalsnaFinance

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake

Stocks Investing.com By Investing.com 13 Jul 2026 12:48 1 min read
BMO raises Merck stock price target to $142 on Keytruda Qlex uptake

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake  Investing.com

BMO raises Merck stock price target to $142 on Keytruda Qlex uptake Investing.com

Read the full story on Investing.com → Opens the original article on news.google.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.